In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HRA Pharma SA

www.hra-pharma.com

Latest From HRA Pharma SA

European OTC Results Round-Up: HRA Pharma, Boiron and Ipsen

HRA Pharma reports impressive sales growth in 2018, thanks largely to acquisitions. A drop in demand for homeopathic medicines hurts Boiron in Q1, while Ipsen enjoys a solid start to the year. 
Sales & Earnings OTC Drugs

HRA Pharma Breaks Into US Consumer Health Market With Mederma Acquisition

EllaOne and Compeed manufacturer HRA Pharma is set to establish a notable presence in the US consumer health market by acquiring the Mederma dermatology range from Germany's Merz.
Deals OTC Drugs

HRA Pharma Launches Three-Hour Courier Service For EllaOne In The UK

HRA Pharma today launches an express courier service for emergency contraceptive EllaOne. Women in London can order EllaOne online and receive the product within three or 12 hours, women in the rest of the UK within 24 hours. 
Health OTC Drugs

EMA’s Frias Defends EU Centralized Switch Procedure Despite Only Delivering Four Reclassifications In 10 Years

Despite delivering only four switches in 10 years, the European Union’s centralized switch procedure was defended by the EMA's Zaide Frias at AESGP's March regulatory conference. Frias pointed to the recent success of HRA Pharma's EllaOne, to the role of pharmacists in driving switches and to the possibility of an OTC Expert Forum as ways forward for the procedure. 
Health OTC Drugs
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • HRA Pharma SA
  • Senior Management
  • Erin Gainer, PhD, CEO
    Saad Harti, Bus. Dev.
  • Contact Info
  • HRA Pharma SA
    Phone: (33) 140331130
    15 Rue Beranger
    Paris, 75003
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register